# Camp4 Therapeutics Corp: Form 8-K, filed Jul 27, 2026

- Company: [Camp4 Therapeutics Corp](/companies/camp.md) (CIK 1736730)
- Form: 8-K
- Filed: 2026-07-27
- Accepted by EDGAR: Jul 27, 2026, 07:01 ET
- Period: 2026-07-27
- Accession: 0001628280-26-049661
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1736730/000162828026049661/camp-20260727.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736730/000162828026049661/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736730/000162828026049661/camp-20260727.htm

Filed Jul 27, 2026.
Source: SEC EDGAR, the filing index for accession 0001628280-26-049661. Last ingested by Listed: Nov 5, 2026, 17:42 ET. No prices; not investment advice.